4
Changes in Ownership
LENZ Therapeutics, Inc. Filed Acc 0000899243-21-027014
Director bought 5,882 shares at $17.00 ($99,994)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shah Smital Director | 2021-06-29 | Purchase | +5,882 | $17.00 | $99,994 | 5,882 | I |
| Derivatives | |||||||
| Shah Smital Director | 2021-04-15 | Grant or award · Stock Option (right to buy) | +93,585 | 93,585 | D | ||
| Open-market purchases · 5,882 sh · avg $17.00 · $99,994 | |||||||
Loading xslF345X03/doc4.xml…